🇺🇸 FDA
Patent

US 11007255

Cancer vaccines and methods of treatment using the same

granted A61KA61K2039/53A61K2039/54

Quick answer

US patent 11007255 (Cancer vaccines and methods of treatment using the same) held by Inovio Pharmaceuticals, Inc. expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/53, A61K2039/54, A61K2039/552, A61K2039/55527